Testing testing, this is what it looks like.

Penn’s one-stop solution for technology commercialization and entrepreneurship

Translating Discoveries

PCI helps to translate University of Pennsylvania discoveries and ideas into new products and businesses for the benefit of society.

We facilitate technology development connections between Penn and the private sector. Whether the end result is a technology license, an R&D alliance, and/or the formation of a new venture, PCI serves as a dedicated one-stop shop for commercial partnering with Penn. Our Team

Featured Technology

Low-cost rapid diagnostic for COVID-19 by Cesar de la Fuente, Ph.D.

View technology

Success Stories

Kymirah Corporate Alliance

Penn partnered with Novartis in 2012 using an innovative and pioneering partnership program model to develop a new and novel method of cancer treatment: CAR-T cell therapy. This landmark alliance led to the development and ultimate launch of Kymriah, a breakthrough new CAR-T medicine providing a personalized cellular therapy for patients with certain leukemias and lymphomas.

Read Success Story

Upcoming Events

All Events

JLABS 101

December 13 @ 12:00 pm

More Info

President’s Innovation Prize Deadline

January 28, 2022

More Info

Johnson & Johnson Nurses Innovate QuickFire Challenge: Healthcare Transformation through Nurse-led Tech

February 4, 2022

More Info

Recent News

All News

By the Numbers – FY20

Top 10

Penn ranked in the top ten as a global R&D Center

$590M

Penn-affiliated startups raised or received in venture capital funding

$116M

Facilitated the highest amount of corporate sponsored research funding in Penn and PCI history

705

Patent applications filed
View Metrics and Reports
Skip to content